Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IVF hartmann Holding AGXSWX:VBSN -0.38%74 ROA % is 10.66% as of Dec. 2025, which is 11% above its 10-year median of 9.63. GuruFocus rates XSWX:VBSN with a GF Score™ of 74/100 and a GF Value™ of CHF143.28 (Fairly Valued). Among 857 Medical Devices & Instruments companies, IVF hartmann Holding AG ranks better than 86.11% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. IVF hartmann Holding AG's annualizedNet Income for the quarter that ended in Dec. 2025 was CHF20.1 Mil.
IVF hartmann Holding AG's average Total Assets over the quarter that ended in Dec. 2025 was CHF188.5 Mil. Therefore, IVF hartmann Holding AG's annualized ROA % for the quarter that ended in Dec. 2025 was 10.66%.
The historical rank and industry rank for IVF hartmann Holding AG's ROA % or its related term are showing as below:
XSWX:VBSN'
s ROA % Range Over the Past 10 Years
Min: 3.51 Med: 9.63 Max: 13.09
Current: 9.7
During the past 13 years, IVF hartmann Holding AG's highest ROA % was 13.09%. The lowest was 3.51%. And the median was 9.63%.
XSWX:VBSN's ROA % is ranked better than 86.11% of 857
companies
in the Medical Devices & Instruments industry
Industry Median: 0.55
vs XSWX:VBSN: 9.70
IVF hartmann Holding AG (XSWX:VBSN) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, IVF hartmann Holding AG's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IVF hartmann Holding AG ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, IVF hartmann Holding AG's ROA % distribution charts can be found below:
* The bar in red indicates where IVF hartmann Holding AG's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
IVF hartmann Holding AG (XSWX:VBSN) has a ROA % of 10.66% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on IVF hartmann Holding AG and its competitors. This is 11% above median its historical median of 9.63. Over the past decade, IVF hartmann Holding AG's ROA % has ranged from 3.51 to 13.09. According to the industry distribution chart, IVF hartmann Holding AG ranks #119 out of 857 companies in the Medical Devices & Instruments industry, placing it in the top 13.9%.
Is IVF hartmann Holding AG's ROA % too high?
IVF hartmann Holding AG's current ROA % of 10.66% is 11% above median its 10-year median of 9.63. Over the past 10 years, this metric has ranged from a low of 3.51 to a high of 13.09. The Medical Devices & Instruments industry median ROA % is 0.55. IVF hartmann Holding AG's value of 10.66% is 1838.2% above this industry median. Based on the distribution chart, IVF hartmann Holding AG ranks #119 out of 857 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, IVF hartmann Holding AG has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does IVF hartmann Holding AG's ROA % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, IVF hartmann Holding AG ranks #119 out of 857 companies for ROA %. This places IVF hartmann Holding AG in the top 14% of its industry — outperforming the majority of peers. The industry median ROA % is 0.55. IVF hartmann Holding AG's value of 10.66% is 1838.2% above this benchmark. Historically, IVF hartmann Holding AG's own ROA % has ranged from 3.51 to 13.09 over the past decade. While the company's 10-year median is 9.63 vs. the industry median of 0.55, IVF hartmann Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.55, based on 857 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IVF hartmann Holding AG's current ROA % of 10.66% is 1838.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on IVF hartmann Holding AG and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IVF hartmann Holding AG's current ROA % is 10.66%, which is 11% above median its own 10-year median of 9.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IVF hartmann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, IVF hartmann Holding AG (XSWX:VBSN) is currently considered Fairly Valued. The stock's GF Value™ is CHF143.28, compared to a current price of CHF132.00 — trading 7.9% below its estimated fair value. The current ROA % is 10.66%, which is 11% above median its 10-year median of 9.63 and 1838.2% above the Medical Devices & Instruments industry median of 0.55. IVF hartmann Holding AG's overall GF Score™ is 74/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For IVF hartmann Holding AG (XSWX:VBSN), the current ROA % is 10.66% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IVF hartmann Holding AG (XSWX:VBSN) Overvalued in 2026?
Based on GuruFocus' analysis, IVF hartmann Holding AG stock appears to be undervalued.
The current stock price of CHF132.00 is trading 7.9% below its estimated GF Value™ of CHF143.28.
GuruFocus considers IVF hartmann Holding AG to be Fairly Valued.
Key valuation signals for XSWX:VBSN:
ROA %: 10.66% (11% above median its 10-year median of 9.63)
GF Value™: CHF143.28 vs. price of CHF132.00 (7.9% below fair value)
Industry Position: 1838.2% above the Medical Devices & Instruments median (#119 of 857)
No single metric tells the full story. See the XSWX:VBSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IVF hartmann Holding AG engages in production and supply of medical, pharmaceutical and hygiene products in Switzerland, it offers products such as surgical disposable, disposable dental, first aid, therapeutic plaster, cotton wool, wound care among others. The company operates in four segment wound care, incontinence management, infection management and Other group activities.
74GF Score
Get the complete analysis for XSWX:VBSN
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:VBSN has been successfully added to your 
